AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 81 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $108,225 | -14.8% | 240,500 | 0.0% | 0.04% | -18.6% |
Q3 2022 | $127,000 | +5.0% | 240,500 | 0.0% | 0.04% | +10.3% |
Q2 2022 | $121,000 | -78.1% | 240,500 | 0.0% | 0.04% | -75.2% |
Q1 2022 | $553,000 | -51.6% | 240,500 | 0.0% | 0.16% | -43.3% |
Q4 2021 | $1,142,000 | -40.3% | 240,500 | 0.0% | 0.28% | -36.2% |
Q3 2021 | $1,912,000 | +14.4% | 240,500 | 0.0% | 0.43% | -16.1% |
Q2 2021 | $1,671,000 | -11.8% | 240,500 | 0.0% | 0.52% | -20.9% |
Q1 2021 | $1,895,000 | +0.1% | 240,500 | 0.0% | 0.65% | +0.9% |
Q4 2020 | $1,893,000 | +11.2% | 240,500 | 0.0% | 0.65% | +78.0% |
Q3 2020 | $1,703,000 | -23.3% | 240,500 | 0.0% | 0.36% | -41.4% |
Q2 2020 | $2,221,000 | +101.2% | 240,500 | 0.0% | 0.62% | -15.3% |
Q1 2020 | $1,104,000 | -39.8% | 240,500 | 0.0% | 0.73% | -17.4% |
Q4 2019 | $1,835,000 | -0.8% | 240,500 | 0.0% | 0.89% | -24.1% |
Q3 2019 | $1,849,000 | +12.9% | 240,500 | 0.0% | 1.17% | +86.1% |
Q2 2019 | $1,638,000 | -15.3% | 240,500 | 0.0% | 0.63% | -63.7% |
Q1 2019 | $1,934,000 | – | 240,500 | – | 1.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 524,929 | $2,588,000 | 6.20% |
DAFNA Capital Management LLC | 349,592 | $1,723,000 | 1.07% |
Nantahala Capital Management | 1,602,903 | $7,902,000 | 0.39% |
Sio Capital Management, LLC | 129,583 | $639,000 | 0.33% |
Rock Springs Capital Management LP | 524,089 | $2,584,000 | 0.12% |
Orbimed Advisors | 1,469,524 | $7,244,000 | 0.07% |
Baker Brothers Advisors | 1,137,872 | $5,609,000 | 0.04% |
Lee Financial Co | 22,408 | $110,000 | 0.04% |
Spark Investment Management LLC | 42,002 | $207,000 | 0.01% |
JENNISON ASSOCIATES LLC | 1,385,067 | $6,565,000 | 0.01% |